Homepage>Company>Media>Pharma News>2022>Hyundai Bioscience to seek fast track processing from US FDA for oral antiviral medicine, CP-COV03, to treat monkeypox Seoul, South Korea
Hyundai Bioscience to seek fast track processing from US FDA for oral antiviral medicine, CP-COV03, to treat monkeypox Seoul, South Korea